Form 4: Tyra Biosciences CFO Boosts Stake via ESPP

Tyra Biosciences Chief Financial Officer Alan Fuhrman acquired 1,376 shares of common stock through an employee stock purchase plan.

Summary

• Alan Fuhrman, Chief Financial Officer of Tyra Biosciences, Inc. (TYRA), acquired 1,376 shares of common stock.
• The acquisition occurred on March 13, 2026, at a price of $9.129 per share.
• These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
• Following this transaction, Alan Fuhrman beneficially owns 16,164 shares of common stock directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating management's confidence in the company's valuation and future prospects through a direct share purchase via an employee plan.

Positives

• The Chief Financial Officer's acquisition of additional shares through an Employee Stock Purchase Plan (ESPP) signals management's confidence in the company's future prospects and valuation.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by key executives like a Chief Financial Officer and through employee stock plans, are often interpreted by the market as a positive signal, indicating management's belief in the company's intrinsic value and future growth potential. This aligns with broader trends where executive share ownership is seen as a mechanism to align management interests with those of shareholders.

Related Party Transactions

• Alan Fuhrman, the Chief Financial Officer, acquired shares from Tyra Biosciences, Inc. through the company's 2021 Employee Stock Purchase Plan, which is a transaction between a related party (insider) and the issuer.

Stakeholder Impact

• Shareholders may view the CFO's increased stake as a positive indicator of management's belief in the company's long-term value, potentially boosting investor confidence.
• Employees participating in the ESPP benefit from the opportunity to acquire company stock at a potentially favorable price, aligning their interests with company performance.

Key Dates

Recommendation

The acquisition of shares by a key executive, the Chief Financial Officer, through an Employee Stock Purchase Plan suggests confidence in the company's long-term value. While a positive signal, this single transaction alone does not warrant a 'strong buy' without further fundamental analysis, thus a 'hold' is prudent for existing investors, and a 'buy' for new investors considering the positive insider sentiment.

Keywords

Tyra Biosciences, TYRA, Alan Fuhrman, CFO, Insider Trading, Stock Purchase, ESPP, Form 4, Beneficial Ownership